stockrowHims & Hers Health, Inc.
HIMS Healthcare Drug Manufacturers Specialty & Generic
Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024.
- Revenue
- +38.3%
- EPS
- −294.7%
- Free cash flow
- +5.09%
- Total debt
- +40.8%
Quarter to June 2026, against a year earlier
Follow HIMS
Alert me
Hims & Hers Health, Inc. (HIMS) Operating cash flow
Hims & Hers Health, Inc.'s operating cash flow for fiscal 2025 was $300.0M, up 19.5% from $251.1M in fiscal 2024. Over the twelve months to 30 June 2026 it was $263.5M. Over the past ten years it has ranged from −$74.9M (fiscal 2019) to $300.0M (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 4 consecutive fiscal years. Hims & Hers Health, Inc. ranks 13th of 84 Drug Manufacturers Specialty & Generic companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $300.0M | 19.48% |
| FY2024 | $251.1M | 241.69% |
| FY2023 | $73.5M | — |
| FY2022 | −$26.5M | — |
| FY2021 | −$34.4M | — |
| FY2020 | −$2.5M | — |
| FY2019 | −$74.9M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | −$35.9M | — |
| Mar 2026 | $89.4M | 45.74% |
| Dec 2025 | $61.3M | (58.77%) |
| Sep 2025 | $148.7M | — |
| 25 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| LNTH Lantheus Holdings, Inc. compare | $409.5M |
| RDY Dr. Reddy's Laboratories Ltd compare | $313.0M |
| HIMS Hims & Hers Health, Inc. | $263.5M |
| ALKS Alkermes plc compare | $243.0M |
| KNSA Kiniksa Pharmaceuticals International, plc compare | $198.8M |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | $180.6M |
| LQDA Liquidia Corporation compare | $167.7M |
| SUPN Indivior Pharmaceuticals Inc. compare | $96.0M |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −$126.6M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on HIMS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- The full statement